Pparδ agonist 5
Pparδ agonist 5, an orally active PPARδ-selective agonist (EC50=0.335 μM), is much greater than that of the prototypical standard GW0742. Pparδ agonist 5 promotes improvements in bone density and microarchitecture in vivo.
For research use only. We do not sell to patients.
- Formula: C23H21F3N2O2S
- Molecular Weight:446.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
PPARδ 0.335 μM (EC50) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 female mice[1]
-
Dosage:10 mg per kg of body weight
-
Administration:P.o.; per day for 6 weeks
-
Result:Improved the bone density at least back to normal (sham control) levels.
Chemical Information
-
Molecular Weight 446.49
-
Formula C23H21F3N2O2S
-
SMILES
OC(/C=C/C1=CC=C(N(C)CC2=C(C)N=C(C3=CC=C(C(F)(F)F)C=C3)S2)C=C1C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pparδ agonist 5 Related Classifications
HY-141494 Related Classifications
Powered by Bioz